Nurse Charged with Tampering with Lorazepam Vials
Department of Justice
U.S. Attorney’s Office
District of Connecticut
FOR IMMEDIATE RELEASE
Friday, October 6, 2023
Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that a federal grand jury in New Haven has returned an indictment charging SEAN FALZARANO, 37, of Southbury, with five counts of tampering with a consumer product.
Falzarano is a Registered Nurse. The indictment alleges that, on January 31, 2022, Falzarano took five vials containing 2mg/ml of Lorazepam solution that he knew was intended to be dispensed to patients, removed the Lorazepam solution from the vials, replaced it with saline, and returned the adulterated vials to be used in medical procedures.
The indictment was returned on October 3. Falzarano appeared today before U.S. Magistrate Judge Maria E. Garcia in New Haven and pleaded not guilty to the charges. He is released on a $50,000 bond pending trial.
Each charge of tampering with a consumer product carries a maximum term of imprisonment of 10 years.
Falzarano’s nursing license is currently suspended.
This matter is being investigated by the Food and Drug Administration, Office of Criminal Investigations; the DEA’s Hartford Diversion Control Division; and the Connecticut Department of Consumer Protection, Drug Control Division. The case is being prosecuted by Assistant U.S. Attorney Ray Miller.
Updated October 6, 2023
________________________________________
Topics
CONSUMER PROTECTION
PRESCRIPTION DRUGS
Component
USAO - Connecticut